Sabra(US:SBRA) ZACKS·2025-11-06 00:16Financial Performance - Sabra Healthcare reported quarterly funds from operations (FFO) of $0.38 per share, matching the Zacks Consensus Estimate and showing an increase from $0.37 per share a year ago [1] - The company posted revenues of $190.04 million for the quarter ended September 2025, which was 1.08% below the Zacks Consensus Estimate, compared to $178 million in the same quarter last year [2] - Over the last four quarters, Sabra has surpassed consensus FFO estimates two times and topped consensus revenue estimates two times [2] Stock Performance and Outlook - Sabra shares have increased by approximately 3.8% since the beginning of the year, while the S&P 500 has gained 15.1% [3] - The future stock price movement will largely depend on management's commentary during the earnings call and the company's FFO outlook [3][4] - The current consensus FFO estimate for the upcoming quarter is $0.38 on revenues of $195.79 million, and for the current fiscal year, it is $1.50 on revenues of $760.6 million [7] Industry Context - The REIT and Equity Trust - Other industry, to which Sabra belongs, is currently ranked in the top 34% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in estimate revisions, which can impact Sabra's stock performance [5][6]